Decision Lab
Decision Lab is a London-based private company that develops digital twin technology for healthcare applications, serving healthcare providers and life sciences organizations across North America and Latin America.
- Company typePrivate
- Founded2011
- HeadquartersLondon, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Decision Lab does
Decision Lab Ltd is a London-based, privately held company founded in 2011 that operates in the digital twin technology space with a stated focus on healthcare applications. According to available source material, the company is positioned as a key player in the U.S. digital twins in healthcare market — a sector valued at US$942.87 million in 2024 and projected to reach US$7,184.78 million by 2033 at a 25.7% CAGR. The company's stated functional scope covers treatment planning, drug discovery, diagnostics, patient monitoring, and healthcare facility management, all of which rely on simulation and predictive analytics enabled by digital twin architectures.
The company operates with a small team of 11–50 employees and serves healthcare providers and life sciences organizations as its primary customer vertical. Its operating geographies include North America (United States and Canada) and Latin America, indicating a cross-Atlantic commercial posture despite the UK headquarters (decisionlab.co.uk). The company describes itself as providing services that solve real-world challenges for some of the biggest and most respected businesses, though specific named customers, product names, pricing models, revenue figures, and management team details are not disclosed in the available sources. No funding rounds, mergers, acquisitions, partnerships, awards, patents, or leadership changes are documented in the input data.
The business model is not explicitly disclosed; no pricing structure, revenue mechanics, or go-to-motion details are available. Decision Lab is listed alongside established players such as GE Healthcare and Twin Health in the same market context, but no competitive differentiation evidence (proprietary technology, customer wins, or technical benchmarks) is provided. Evidence gaps — particularly around revenue, customers, leadership, and product portfolio — limit confident assessment of scale, unit economics, and growth cadence.
Decision Lab firmographics
Firmographics- Name
- Decision Lab
- Legal name
- Decision Lab Ltd
- Website
- https://decisionlab.co.uk
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Decision Lab is a London-based private company that develops digital twin technology for healthcare applications, serving healthcare providers and life sciences organizations across North America and Latin America.
- Ownership category
- akta.pro rank
Decision Lab industry classification
Industry- Product category
- Healthcare Digital Twin Software
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Diagnostic & Triage Decision Support (HLACAGAA)
- akta.pro secondary industries
- Lab Analytics, Utilization Management & Operational Intelligence (HLACAMAK), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
Keywords
Where Decision Lab is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Markets served
Decision Lab business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Decision Lab product offering
Product offeringCore offering
Decision Lab provides digital twin technology applied to healthcare, enabling simulation and predictive analytics for treatment planning, drug discovery, diagnostics, patient monitoring, and healthcare facility management. The offering is targeted at healthcare providers and life sciences organizations seeking personalized medicine and treatment optimization capabilities.
Product overview
Decision Lab Ltd is identified as a key player in the U.S. digital twins in healthcare market. The available source data does not provide specific information about the company's individual products, modules, or service offerings. Based on the market context, the company appears to be involved in healthcare simulation and digital twin technology, but no named products or detailed portfolio information is available in the provided sources.
Differentiator
Problem solved
Functional benefit
Companies that use Decision Lab
Customer profileSegments1 record
Ideal customer profiles1 record
Decision Lab technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Decision Lab partnerships and signals
Strategic signalScale indicators1 record
Recent moves3 records
Expansion highlights2 records
Decision Lab competitors and assessment
Company assessmentBroad incumbents
- Siemens Healthineers: Siemens Healthineers operates a broad portfolio in medical imaging, diagnostics, and digital health, including digital twin simulations for cardiovascular and oncology applications. Comparable as a large incumbent offering digital twin solutions within a wider healthcare portfolio.
- GE Healthcare: GE Healthcare is a major medical technology and digital solutions provider with growing digital twin capabilities across imaging, asset management, and care delivery. Cited in the source data as an established player alongside Decision Lab in the digital twins in healthcare market.
- Philips HealthSuite: Philips HealthSuite integrates connected health devices, clinical informatics, and patient monitoring, increasingly incorporating digital twin concepts for care pathways. A broad incumbent with overlapping patient monitoring and clinical decision support offerings.
Direct peers
- Twin Health: Twin Health builds AI-driven digital twin platforms for personalized whole-body metabolic care, primarily in chronic disease management. Directly comparable as a digital twin healthcare specialist explicitly cited alongside Decision Lab as a key market player.
- Dassault Systèmes (Living Heart Project): Dassault Systèmes' Living Heart Project applies digital twin simulation to cardiac and broader life sciences R&D and treatment planning. Directly comparable in using digital twins for treatment planning, drug discovery, and diagnostics in healthcare.
Emerging players
- Q Bio: Q Bio builds a whole-body digital twin platform combining imaging and clinical data for preventive health assessments. Comparable as an emerging digital twin healthcare company focused on diagnostics and patient monitoring.
- HeartFlow: HeartFlow creates patient-specific 3D digital heart models from CT imaging to support diagnosis and treatment planning for coronary artery disease. Comparable as a clinical decision support company whose core product is a patient-level digital twin.
- Unlearn.AI: Unlearn.AI builds AI-generated digital twin prognostic models to improve clinical trial efficiency and biopharma R&D. Comparable as an emerging specialist applying digital twin methodology to drug discovery and clinical research workflows.
- Virtonomy: Virtonomy provides patient-specific digital twin simulations for medical device design, clinical trials, and in-silico testing. Comparable as an emerging digital twin specialist serving life sciences R&D and treatment planning use cases.
- Materialise (Medical): Materialise provides 3D planning, patient-specific anatomical models, and digital twin tools for surgical planning and personalized care. Comparable as a specialist applying digital modeling to diagnostics, treatment planning, and healthcare simulation.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights5 records
Customer concentration
Decision Lab social profiles
Digital presenceDecision Lab financial estimates
Financial estimateRevenue estimate
Valuation estimate
Decision Lab leadership team
Management profileNumber of profiles
Decision Lab funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Decision Lab M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Decision Lab
What does Decision Lab do?
Decision Lab provides digital twin technology applied to healthcare, enabling simulation and predictive analytics for treatment planning, drug discovery, diagnostics, patient monitoring, and healthcare facility management. The offering is targeted at healthcare providers and life sciences organizations seeking personalized medicine and treatment optimization capabilities.
Is Decision Lab a public or private company?
Decision Lab is a private company. It is classified as unknown and is currently operating.
When was Decision Lab founded?
Decision Lab was founded in 2011. It employs 11 to 50 people.
Where is Decision Lab based?
Decision Lab is headquartered in London, United Kingdom, in the Europe region.
Who are Decision Lab's main competitors?
Broad incumbents on record are Siemens Healthineers, GE Healthcare and Philips HealthSuite. Direct peers are Twin Health and Dassault Systèmes (Living Heart Project). Emerging players are Q Bio, HeartFlow, Unlearn.AI, Virtonomy and Materialise (Medical).
Does Decision Lab have an API?
No public API is recorded for Decision Lab.
What industry is Decision Lab in?
Decision Lab's product category is Healthcare Digital Twin Software. Its primary akta.pro industry code is HLACAGAA, Diagnostic & Triage Decision Support, with a secondary code of HLACAMAK, Lab Analytics, Utilization Management & Operational Intelligence. Its NAICS code is 54171 and its SIC code is 8731.